Regeneron Pharmaceuticals (($REGN)) announced an update on their ongoing clinical study. Regeneron Pharmaceuticals, in collaboration with Bayer, ...
Highly experienced biopharma financial officer joins leadership team CFO hire bolsters Kalaris’ leadership team and supports continued growth of ...
Highly experienced biopharma financial officer joins leadership team CFO hire bolsters Kalaris' leadership team and supports continued growth of the company as it enrolls its Phase 1b/2 study in treat ...
RESEARCH TRIANGLE PARK, N.C., Nov. 03, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today reported financial results for the third quarter ended September 30, 2025, and ...
GlobalData on MSN
4DMT and Otsuka to advance eye disease treatment in APAC
D Molecular Therapeutics (4DMT) has announced an exclusive licence agreement with Otsuka Pharmaceutical to develop and market 4D-150.
The Healthy @Reader's Digest on MSN
“What I Wish I’d Known About Cataract Surgery”: A Doctor Details What Patients Should Know About a Common Procedure
An expert MD reveals clear insights into cataract surgery, spotlighting the breakthroughs in treatment: "We live in a time of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback